<DOC>
	<DOCNO>NCT01892462</DOCNO>
	<brief_summary>The purpose study determine whether level inflammatory marker circulate blood correlate risk dangerous heart rhythm . Patients systolic heart failure , show increase risk dangerous heart rhythm , enrol . All subject implantable cardioverter-defibrillator ( ICD ) place , allow regular evaluation heart rhythm .</brief_summary>
	<brief_title>Circulating Biomarkers Ventricular Tachyarrhythmia</brief_title>
	<detailed_description>If agree study , ask following thing : - come EP device clinic every three month one year device interrogate complete EKG - lab drawn measure level certain marker inflammation body . This information use identify new way test risk abnormal heart rhythms heart disease - review medication study coordinator along recent illness hospitalization</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>leave ventricular ejection fraction [ LVEF ] &lt; =35 % ICD implant Recent myocardial infarction ( 12 week ) Recent revascularization ( 12 week ) Recent hospitalization cause ( 6 week ) History rheumatologic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>